239 related articles for article (PubMed ID: 8490496)
1. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
[TBL] [Abstract][Full Text] [Related]
2. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
[TBL] [Abstract][Full Text] [Related]
3. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.
Bourne T; Campbell S; Steer C; Whitehead MI; Collins WP
BMJ; 1989 Dec; 299(6712):1367-70. PubMed ID: 2513965
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound screening for familial ovarian cancer.
Bourne TH; Whitehead MI; Campbell S; Royston P; Bhan V; Collins WP
Gynecol Oncol; 1991 Nov; 43(2):92-7. PubMed ID: 1743564
[TBL] [Abstract][Full Text] [Related]
5. Transabdominal ultrasound screening for early ovarian cancer.
Campbell S; Bhan V; Royston P; Whitehead MI; Collins WP
BMJ; 1989 Dec; 299(6712):1363-7. PubMed ID: 2513964
[TBL] [Abstract][Full Text] [Related]
6. Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging.
Weiner Z; Beck D; Shteiner M; Borovik R; Ben-Shachar M; Robinzon E; Brandes JM
J Ultrasound Med; 1993 Jul; 12(7):387-93. PubMed ID: 8355333
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
[TBL] [Abstract][Full Text] [Related]
10. Psychological impact of screening for familial ovarian cancer.
Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
[TBL] [Abstract][Full Text] [Related]
11. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
[TBL] [Abstract][Full Text] [Related]
12. Ovarian status in healthy postmenopausal women.
Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
[TBL] [Abstract][Full Text] [Related]
13. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer.
Bourne TH; Campbell S; Reynolds K; Hampson J; Bhatt L; Crayford TJ; Whitehead MI; Collins WP
Gynecol Oncol; 1994 Mar; 52(3):379-85. PubMed ID: 8157195
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
15. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D
BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497
[TBL] [Abstract][Full Text] [Related]
16. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
BJOG; 2014 Dec; 121 Suppl 7():35-9. PubMed ID: 25488086
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
Hensley ML; Robson ME; Kauff ND; Korytowsky B; Castiel M; Ostroff J; Hurley K; Hann LE; Colon J; Spriggs D
Gynecol Oncol; 2003 Jun; 89(3):440-6. PubMed ID: 12798709
[TBL] [Abstract][Full Text] [Related]
19. Early detection of familial ovarian cancer.
Dørum A; Kristensen GB; Abeler VM; Tropé CG; Møller P
Eur J Cancer; 1996 Sep; 32A(10):1645-51. PubMed ID: 8983269
[TBL] [Abstract][Full Text] [Related]
20. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
